April 25, 2023, VANCOUVER, BC -GeniusHealth Therapeutics, a company dedicated to improving healthcare for individuals with neurodevelopmental disorders (NDD), is pleased to announce that Dr. Rachal Yang has been appointed as the Senior Advisor and Interim Chief Product Officer.

Dr. Yang is an accomplished professional with a unique and diverse background in medicine, basic research, drug research and development, and healthcare information technology. She is an active philanthropist and patient advocate dedicated to improving the lives of those suffering from rare diseases and hardships. Dr. Yang is also an angel investor and mentor, providing guidance and support to early startup entrepreneurs. Dr. Yang is active on the global stage, tirelessly working to improve access to adequate healthcare and the quality of life of underrepresented and underserved patients.

Andy Yu, CEO of GeniusHealth Therapeutics, said, “We are thrilled to have Dr. Yang join our team. With her extensive knowledge and experience in healthcare, Dr. Yang will sigificantly aid our efforts in developing innovative and effective digital therapeutics to patients with NDDs. We are racing to deliver digital diagnostics and personalized treatments for patients with these disorders.”

As the Senior Advisor and Interim Chief Product Officer, Dr. Yang will foster a culture of innovation and collaboration, bringing together researchers, clinicians, patients, and other stakeholders to accelerate the development of new therapies for NDDs. She will work closely with the CEO and the product team to ensure that the company’s products meet the needs of patients and their families, align with company’s overall strategy and mission, and are developed and commercialized in a timely and efficient manner.

“I am excited to join the GeniusHealth team, and have the opportunity to drive technological innovation forward to meet the unmet medical needs of those with cognitive impairments”, said Dr. Yang, “and I look forward to working with the team and making a difference.”

GeniusHealth Therapeutics was founded with the mission of helping every behavioral and neuro-disorder genius achieve their life goals. The company is committed to challenging the status quo of medicine and care delivery to help people living with ADHD, ASD, and other cognitive impairments and their families. GeniusHealth Therapeutics aims to bring together top research and clinical know-how with multicultural experiences to revolutionize how medicine is designed and delivered.

For more information on GeniusHealth Therapeutics and its mission to revolutionize healthcare for individuals with neurodevelopmental disorders, please visit www.geniushealth.care